Skip to content

Efficacy of Pea Hull Fibre Supplementation

Efficacy of Pea Hull Fibre Supplementation on Gastrointestinal Transit Time-induced Reduction in Proteolytic Fermentation and Enhancement of Wellness in Older Adults.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02778230
Enrollment
35
Registered
2016-05-19
Start date
2016-06-30
Completion date
2018-12-27
Last updated
2019-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

fiber, gastrointestinal, microbiota

Brief summary

The purpose of this randomized, cross-over study is to explore the effects of pea hull fiber on bowel movement frequency, transit time, appetite, gastrointestinal symptoms, microbiota composition and activity.

Detailed description

A 10-week randomized, cross-over study will be carried out to assess the efficacy of pea hull fiber. Participants will complete a 2-week baseline period during which appetite, gastrointestinal symptoms, stool frequency, and stool consistency (transit time) will be collected by paper questionnaire, and participants will collect a single stool. Dietary data (24-hour dietary recalls) will be obtained via phone interviews 3 times during the baseline period. On or about day 15, participants will attend a study visit and complete the Simplified Nutritional Appetite Questionnaire (SNAQ) and Gastrointestinal Symptom Response Scale (GSRS). Participants will be randomized on or about day 15 and consume snacks without pea hull fiber for a 2-week control period, and snacks with added pea hull fiber for a 2-week treatment period separated by a 2-week washout period. In both intervention periods, participants will complete daily questionnaires to assess appetite, gastrointestinal symptoms, and stool frequency and consistency (transit time). Furthermore, they will complete SNAQ and GSRS after the end of each intervention period. The 24-hour dietary recalls will also be collected 3 times during each of the intervention periods. Participants will undergo an additional 2-week washout period after the second intervention period. During washout periods, the same data will be collected as was done during the baseline and intervention periods.Participants will be asked to collect one stool during pre-baseline and weeks 4, 6, 8 and 10 for a total of 5 stools. Stool samples will be analyzed for changes in the microbiota.

Interventions

DIETARY_SUPPLEMENTPea Fiber

Snacks (2 baked goods) fortified with 5 g pea hull fiber

DIETARY_SUPPLEMENTControl

Snacks (2 baked goods) without fiber fortification.

Sponsors

Saskatchewan Pulse Growers
CollaboratorOTHER
University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Willing to have height and weight measured and provide demographic information (e.g. age, race, sex). * Willing to consume pea hull fiber and control snacks daily each for a 2-week period * Willing to complete a daily questionnaire regarding general and gastrointestinal wellness throughout the entire 10-weeks study. * Willing to complete the GSRS (Gastrointestinal Symptom Rating Scale) and SNAQ questionnaires bi-weekly at study appointments. * Willing to be interviewed for a 24-hr food recall, 3 times per 2-weeks period throughout the study. * Willing to provide 5 stool samples, one in each 2-weeks period throughout the study. * Willing and be able to provide a valid social security for study payment purposes.

Exclusion criteria

* Have any known food allergies. * Are currently taking medications for diarrhea. * Have taken antibiotics within the past four weeks prior to randomization. * Are currently taking probiotics supplements and do not want to discontinue a minimum of two weeks prior to the study. * Have previously or are currently being treated for any diseases or illnesses such as gastrointestinal disease (gastric ulcers, Crohn's, Celiac, ulcerative colitis, etc.).

Design outcomes

Primary

MeasureTime frameDescription
Stool consistency rating by Bristol Stool Form ScaleChanges from baseline to week 4, 6, 8 and 10.Assesses estimated transit time.

Secondary

MeasureTime frameDescription
Number of bowel movements per day averaged by weekChanges from baseline to week 4, 6, 8, and 10stool frequency
Microbiota profile changes: percent change at phylum and genus levels; changes in OTUsChanges from baseline to week 4, 6, 8, and 10
GSRS (Gastrointestinal Symptom Response Scale) score.Changes from baseline to week 4, 6, 8, and 10
SNAQ (Simplified Nutritional Appetite Questionnaire) score.Changes from baseline to week 4, 6, 8, and 10

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026